Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of participants at baseline

From: Vitamin D3 supplementation and treatment outcomes in patients with depression (D3-vit-dep)

  Intervention group (n = 28) Control group (n = 34) Total (n = 62)
Female, n (%) 21 (75.0) 23 (67.7) 47 (69.1)
Age (years), mean (SD) 39.6 (13.5) 38.7 (11.4) 39.1 (12.3)
Normal 25(OH)D (≥ 50 nmol/L), n (%) 10 (35.6) 13 (38.2) 23 (35.5)
Insufficient 25(OH)D (25–50 nmol/L), n (%) 11 (39.3) 11 (32.4) 22 (35.5)
Deficient 25(OH)D (< 25 nmol/L), n (%) 7 (25.0) 10 (29.4) 17 (27.4)
SSRI, n (%)* 17 (60.7) 12 (35.3) 29 (46.8)
SNRI, n (%) 12 (42.9) 18 (52.9) 30 (48.4)
Depression (HAM-D17), mean (SD) 18 (6) 18 (6) 18 (6)
  1. SSRI selective serotonin reuptake inhibitor, SNRI serotonin–norepinephrine reuptake inhibitors
  2. * Significantly different between the two groups (p = 0.046)